Stryker (SYK) vs West Pharmaceutical Services (WST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
West Pharmaceutical Services (WST) has outperformed Stryker (SYK) over the past year, gaining 44.0% versus a loss of 15.8%. Over five years, SYK leads with a +27.3% price change compared with -11.1% for WST. Stryker is the larger company by market cap ($118.01 billion vs $27.19 billion), about 4.3 times the size.
On valuation, Stryker trades at a lower forward P/E (19.0x vs 37.6x for West Pharmaceutical Services). Stryker offers the higher dividend yield (1.14% vs 0.23%). West Pharmaceutical Services converts more of its revenue into profit, with a net margin of 16.1% versus 12.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SYK | WST |
|---|---|---|
| Share price | $310.00 | $390.30 |
| Market cap | $118.01B | $27.19B |
| 1-day change | -0.98% | -1.61% |
| YTD return | -11.80% | +41.86% |
| 1-year return | -15.82% | +43.98% |
| 5-year return | +27.32% | -11.07% |
| P/E ratio (TTM) | 33.01 | 43.80 |
| Forward P/E | 19.03 | 37.55 |
| EPS (TTM) | $9.39 | $8.91 |
| Dividend yield | 1.14% | 0.23% |
| Annual dividend | $3.52 | $0.88 |
| Revenue (latest FY) | $25.12B | $3.07B |
| Revenue growth (YoY) | +11.16% | +6.25% |
| Net income (latest FY) | $3.25B | $493.70M |
| Gross margin | 63.96% | 35.91% |
| Operating margin | 19.47% | 19.03% |
| Net margin | 12.92% | 16.06% |
| 52-week high | $389.33 | $438.27 |
| 52-week low | $267.00 | $223.83 |
| Distance from 52-week high | -20.38% | -10.95% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +9.47% | +20.68% |
| Average volume | 2.93M | 619.05K |
| Shares outstanding | 380.69M | 69.66M |
| Employees | 56,000 | 10,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stryker is about 4.3 times larger than West Pharmaceutical Services by market value ($118.01B vs $27.19B).
- WST has outperformed SYK by 59.8 percentage points over the past year.
- West Pharmaceutical Services trades at a higher earnings multiple (43.8x vs 33.0x trailing P/E).
About Stryker
SYK stock →Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Health Care · Medical/Dental Instruments · 56,000 employees
About West Pharmaceutical Services
WST stock →West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 10,000 employees
SYK vs WST FAQ
Which is bigger, Stryker or West Pharmaceutical Services?
Stryker (SYK) is larger, with a market capitalization of $118.01B compared with $27.19B for West Pharmaceutical Services (WST).
Which stock has performed better over the past year, SYK or WST?
WST returned +43.98% over the past 12 months, compared with -15.82% for SYK (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, SYK or WST?
SYK has the lower trailing P/E at 33.0, versus 43.8 for WST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Stryker or West Pharmaceutical Services?
Stryker has the higher yield at 1.14%, compared with 0.23% for West Pharmaceutical Services.
Are Stryker and West Pharmaceutical Services in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.